63 Avsnitt

  1. ASO Series: Targeting Patient-Derived Orthotopic Gastric Cancers with a Fluorescent Humanized Anti-CEA Antibody

    Publicerades: 2024-12-10

  2. ASO Series: A Four-Arm Randomized Clinical Trial of Topical Pain Control for Sentinel Node Radiotracer Injections in Patients with Breast Cancer

    Publicerades: 2024-11-19

  3. Adjuvant Chemoradiation in Resected Biliary Adenocarcinoma: Evaluation of SWOG S0809 with a Large National Database

    Publicerades: 2024-10-08

  4. SSO2024 Abstract: Lower Social Support Predicts Higher Cortisol for Breast Cancer Patients in Disadvantaged Neighborhoods

    Publicerades: 2024-09-10

  5. Practice Patterns and Outcomes Among Surgical Oncology Fellowship Graduates Performing Complex Cancer Surgery in the United States Across Different Career Stages

    Publicerades: 2024-08-13

  6. Extent of Resection and Long-Term Outcomes for Appendiceal Adenocarcinoma: a SEER Database Analysis of Mucinous and non-Mucinous Histologies

    Publicerades: 2024-07-16

  7. Docetaxel‑Based Neoadjuvant Chemotherapy Followed by En Bloc Resection for Esophageal Adenocarcinoma: A 15‑Year Retrospective Analysis from a Regional Upper Gastrointestinal Cancer Network

    Publicerades: 2024-06-11

  8. The Landmark Series—Addressing Disparities in Breast Cancer Screening: New Recommendations for Black Women

    Publicerades: 2024-05-21

  9. Standardization of Colon Resection for Cancer: An Overview of the American College of Surgeons Commission on Cancer Standard 5.6

    Publicerades: 2024-04-09

  10. Hepatectomy Before Primary Tumor Resection as Preferred Approach for Synchronous Liver Metastases from Rectal Cancer

    Publicerades: 2024-03-12

  11. Hospital Designations and Their Impact on Guideline-Concordant Care and Survival in Pancreatic Cancer. Do They Matter?

    Publicerades: 2024-02-13

  12. Benchmarks and Geographic Differences in Gallbladder Cancer Surgery: An International Multicenter Study

    Publicerades: 2024-01-09

  13. CA19-9 Response to First-Line Neoadjuvant FOLFIRINOX and Second-Line Gemcitabine/Nab-Paclitaxel for Patients with Operable Pancreatic Cancer

    Publicerades: 2023-12-12

  14. Neuroendocrine Tumor Liver Metastases: Long-Term Follow-up Evaluation of More Than 500 Patients

    Publicerades: 2023-11-14

  15. Endocrine Therapy for Surgeons: Practical Pearls for Managing Menopausal, Bone Loss and Sexual Adverse Effects

    Publicerades: 2023-10-10

  16. Impact of the Histologic Pattern of Residual Tumor After Neoadjuvant Chemotherapy on Recurrence and Survival in Stage I–III Breast Cancer

    Publicerades: 2023-09-12

  17. Long-Term Survival in Patients Treated with Cytoreduction and Heated Intraperitoneal Chemotherapy for Peritoneal Mesothelioma at a Single High-Volume Center

    Publicerades: 2023-08-08

  18. Exploring the Potential of Artificial Intelligence in Surgery: Insights from a Conversation with ChatGPT

    Publicerades: 2023-07-11

  19. A Model to Predict Treatment Failure in Patients Undergoing Upfront Surgery for Resectable Colorectal Liver Metastases

    Publicerades: 2023-06-13

  20. Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients

    Publicerades: 2023-05-09

1 / 4

"Speaking of SurgOnc" is a podcast series brought to you by the Annals of Surgical Oncology (ASO) and the Society of Surgical Oncology(SSO). Dr. Frederick L. (Rick) Greene, ASO Deputy Editor, will explore and expand upon ideas and concepts described in articles published in the Annals of Surgical Oncology. Dr. Greene will interview authors and leading experts about topics of current importance in surgical oncology.

Visit the podcast's native language site